950 related articles for article (PubMed ID: 19251712)
21. Strong protective effect of DR3 against ulcerative colitis in the Spanish population.
Gómez-García M; Oliver J; Márquez A; Mendoza JL; López-Nevot MA; Fernández-Arquero M; González-Escribano MF; Díaz-Rubio M; de la Concha EG; Urcelay E; Martín J; Martínez A
Am J Gastroenterol; 2007 Dec; 102(12):2762-6. PubMed ID: 17714554
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
[TBL] [Abstract][Full Text] [Related]
23. Hla-B genotype in Japanese patients with Crohn's disease.
Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
[TBL] [Abstract][Full Text] [Related]
24. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.
Bittencourt PL; Farias AQ; Porta G; Cançado EL; Miura I; Pugliese R; Kalil J; Goldberg AC; Carrilho FJ
J Clin Gastroenterol; 2008 Mar; 42(3):300-5. PubMed ID: 18223493
[TBL] [Abstract][Full Text] [Related]
25. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
[TBL] [Abstract][Full Text] [Related]
26. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
Tedde A; Laura Putignano A; Bagnoli S; Congregati C; Milla M; Sorbi S; Genuardi M; Papi L
Scand J Gastroenterol; 2008; 43(6):712-8. PubMed ID: 18569989
[TBL] [Abstract][Full Text] [Related]
28. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
30. [The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases].
Matri S; Boubaker J; Hamzaoui S; Bardi R; Ayed K; Filali A
Tunis Med; 2003 May; 81(5):289-94. PubMed ID: 12934447
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
Chauhan B; Santiago L; Hutcheson PS; Schwartz HJ; Spitznagel E; Castro M; Slavin RG; Bellone CJ
J Allergy Clin Immunol; 2000 Oct; 106(4):723-9. PubMed ID: 11031343
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
[TBL] [Abstract][Full Text] [Related]
34. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
Okada Y; Yamazaki K; Umeno J; Takahashi A; Kumasaka N; Ashikawa K; Aoi T; Takazoe M; Matsui T; Hirano A; Matsumoto T; Kamatani N; Nakamura Y; Yamamoto K; Kubo M
Gastroenterology; 2011 Sep; 141(3):864-871.e1-5. PubMed ID: 21699788
[TBL] [Abstract][Full Text] [Related]
35. MHC class I chain-related gene A-A5.1 allele is associated with ulcerative colitis in Chinese population.
Ding Y; Xia B; Lü M; Zhang Y; Li J; Ye M; Luo H; Yu J; Zhang X; Tan J
Clin Exp Immunol; 2005 Oct; 142(1):193-8. PubMed ID: 16178876
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.
Festen EA; Stokkers PC; van Diemen CC; van Bodegraven AA; Boezen HM; Crusius BJ; Hommes DW; van der Woude CJ; Balschun T; Verspaget HW; Schreiber S; de Jong DJ; Franke A; Dijkstra G; Wijmenga C; Weersma RK
Am J Gastroenterol; 2010 Feb; 105(2):395-402. PubMed ID: 19861958
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
39. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J
Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171
[TBL] [Abstract][Full Text] [Related]
40. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis.
Tominaga K; Fujii S; Mukawa K; Fujita M; Ichikawa K; Tomita S; Imai Y; Kanke K; Ono Y; Terano A; Hiraishi H; Fujimori T
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8880-5. PubMed ID: 16361578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
